VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Female at birth and identifies as female gender    │ Female at birth and identifies as female gender    │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Age 18 years or older                              │ Age 18 years or older                              │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Able to understand and provide consent in English  │ Able to understand and provide consent in English  │     100 │
│ or Spanish                                         │ or Spanish                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ HIV negative by 4th generation test (Ag/Ab test)   │ HIV negative by 4th generation test (Ag/Ab test)   │     100 │
│ or combination of enzymeimmunoassay (EIA) and HIV  │ or combination of enzymeimmunoassay (EIA) and HIV  │         │
│ RNA                                                │ RNA                                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Condomless sex in the last 3 months with one or    │ Condomless sex in the last 3 months with one or    │     100 │
│ more male partners of unknown HIV status known to  │ more male partners of unknown HIV status known to  │         │
│ be at substantial risk of HIV infection (IDU,      │ be at substantial risk of HIV infection (IDU,      │         │
│ bisexual, sex for goods, recently incarcerated,    │ bisexual, sex for goods, recently incarcerated,    │         │
│ from a country with HIV prevalence \>1%,           │ from a country with HIV prevalence >1%,            │         │
│ interpersonal Partner Violence)                    │ interpersonal Partner Violence)                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ STI (rectal or vaginal gonorrhea or syphilis)      │ STI (rectal or vaginal gonorrhea or syphilis)      │     100 │
│ diagnosis during the last 6 months                 │ diagnosis during the last 6 months                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Previous post-exposure prophylaxis (PEP) use       │ Previous post-exposure prophylaxis (PEP) use       │     100 │
│ during the last 12 months                          │ during the last 12 months                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Sex for exchange of money, goods or services       │ Sex for exchange of money, goods or services       │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pregnancy at enrollment                            │ Pregnancy at enrollment                            │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Any condition, which in the opinion of the         │ Any condition, which in the opinion of the         │     100 │
│ provider, will seriously compromise the            │ provider, will seriously compromise the            │         │
│ participant's ability to comply with the protocol, │ participant's ability to comply with the protocol, │         │
│ including adherence to PrEP medication dosing,     │ including adherence to PrEP medication dosing,     │         │
│ such as active, untreated or unstable major mental │ such as active, untreated or unstable major mental │         │
│ illness (i.e. untreated psychotic disorder)        │ illness (i.e. untreated psychotic disorder)        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Use of prohibited medications, in particular,      │ Use of prohibited medications, in particular,      │     100 │
│ agents known to be nephrotoxic or drugs slow in    │ agents known to be nephrotoxic or drugs slow in    │         │
│ renal excretion                                    │ renal excretion                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Previous participation in an HIV vaccine trial.    │ Previous participation in an HIV vaccine trial.    │     100 │
│ Participants that were documented to have received │ Participants that were documented to have received │         │
│ only placebo are not excluded                      │ only placebo are not excluded                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Signs or symptoms suspicious for Primary HIV       │ Signs or symptoms suspicious for Primary HIV       │     100 │
│ Infection (PHI)                                    │ Infection (PHI)                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Creatinine clearance ≥ 60 ml/min (via Cockcroft-   │ Creatinine clearance = 60 ml/min (via Cockcroft-   │      98 │
│ Gault formula)                                     │ Gault formula)                                     │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has at least one HIV-infected sexual partner for   │ Has at least one HIV-infected sexual partner for   │      98 │
│ ≥4 weeks                                           │ =4 weeks                                           │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤═══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                     │   Score │
╞═══════════════════════════════════╪═══════════════════════════════════════════════════╪═════════╡
│ Must be FEMALE                    │ Able to understand and provide consent in English │      19 │
│                                   │ or Spanish                                        │         │
├───────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ At-Risk Criteria (at least one)   │ Age 18 years or older                             │      38 │
├───────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 18 Years │ Has at least one HIV-infected sexual partner for  │      40 │
│                                   │ =4 weeks                                          │         │
╘═══════════════════════════════════╧═══════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 97
Average Levenshtein Ratio of individual lines: 88.5
OverAll Ratio: 92.75
